Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda

BySusan Haigney

August 11th 2026

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

ByLee Karras,Zachary Zubulake

August 11th 2026

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

ByBrian Drapeau

August 10th 2026

Bristol-Myers Squibb’s new facility is a part of a $40 billion commitment the company pledged to invest in research and development, technology and domestic manufacturing | Image Courtesy of Bristol-Myers Squibb

BMS Bets on Flexible Capacity With $2.3B Texas Campus

ByZachary Zubulake

August 10th 2026

Copenhagen city skyline in Denmark at famous old Nyhavn port | Image Credit: ©f11photo -stock.adobe.com

Danish Biotechs Attracting Investor Attention

ByCheryl Barton

August 10th 2026

February 2003

Articles in this issue

Related Content

CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

BMS Bets on Flexible Capacity With $2.3B Texas Campus

Danish Biotechs Attracting Investor Attention

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Danish Biotechs Attracting Investor Attention

Three Formats, One Platform: Halo's New Sterile Fill-Finish Line

CPHI Milan Adds Sustainability Summit and New AI, Cold Chain, and Labeling Zones to 2026 Agenda

BMS Bets on Flexible Capacity With $2.3B Texas Campus